Medcorp Limited (TTSE:MED)

Medcorp Statistics

Total Valuation

Medcorp has a market cap or net worth of TTD 342.56 million. The enterprise value is 405.49 million.

Market Cap	342.56M
Enterprise Value	405.49M

Important Dates

The next estimated earnings date is Thursday, May 28, 2026.

Earnings Date	May 28, 2026
Ex-Dividend Date	Feb 13, 2026

Share Statistics

Medcorp has 7.83 million shares outstanding. The number of shares has increased by 2.94% in one year.

Current Share Class	7.83M
Shares Outstanding	7.83M
Shares Change (YoY)	+2.94%
Shares Change (QoQ)	+7.83%
Owned by Insiders (%)	82.96%
Owned by Institutions (%)	n/a
Float	1.33M

Valuation Ratios

The trailing PE ratio is 17.22.

PE Ratio	17.22
Forward PE	n/a
PS Ratio	2.80
PB Ratio	3.36
P/TBV Ratio	3.36
P/FCF Ratio	23.87
P/OCF Ratio	22.22
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.32, with an EV/FCF ratio of 28.26.

EV / Earnings	20.73
EV / Sales	3.31
EV / EBITDA	10.32
EV / EBIT	16.76
EV / FCF	28.26

Financial Position

The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.93.

Current Ratio	2.52
Quick Ratio	2.21
Debt / Equity	0.93
Debt / EBITDA	2.57
Debt / FCF	6.59
Interest Coverage	5.40

Financial Efficiency

Return on equity (ROE) is 21.17% and return on invested capital (ROIC) is 12.57%.

Return on Equity (ROE)	21.17%
Return on Assets (ROA)	6.29%
Return on Invested Capital (ROIC)	12.57%
Return on Capital Employed (ROCE)	11.37%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	122.54M
Profits Per Employee	19.56M
Employee Count	1
Asset Turnover	0.57
Inventory Turnover	8.53

Taxes

In the past 12 months, Medcorp has paid 615,037 in taxes.

Income Tax	615,037
Effective Tax Rate	3.05%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	44.05
200-Day Moving Average	47.81
Relative Strength Index (RSI)	0.04
Average Volume (20 Days)	14

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medcorp had revenue of TTD 122.54 million and earned 19.56 million in profits. Earnings per share was 2.54.

Revenue	122.54M
Gross Profit	61.85M
Operating Income	21.68M
Pretax Income	20.18M
Net Income	19.56M
EBITDA	25.33M
EBIT	21.68M
Earnings Per Share (EPS)	2.54

Balance Sheet

The company has 31.66 million in cash and 94.58 million in debt, with a net cash position of -62.92 million or -8.04 per share.

Cash & Cash Equivalents	31.66M
Total Debt	94.58M
Net Cash	-62.92M
Net Cash Per Share	-8.04
Equity (Book Value)	101.95M
Book Value Per Share	13.30
Working Capital	38.20M

Cash Flow

In the last 12 months, operating cash flow was 15.42 million and capital expenditures -1.07 million, giving a free cash flow of 14.35 million.

Operating Cash Flow	15.42M
Capital Expenditures	-1.07M
Depreciation & Amortization	3.65M
Net Borrowing	-16.23M
Free Cash Flow	14.35M
FCF Per Share	1.83

Margins

Gross margin is 50.48%, with operating and profit margins of 17.69% and 15.96%.

Gross Margin	50.48%
Operating Margin	17.69%
Pretax Margin	16.46%
Profit Margin	15.96%
EBITDA Margin	20.67%
EBIT Margin	17.69%
FCF Margin	11.71%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 4.57%.

Dividend Per Share	2.00
Dividend Yield	4.57%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	22.70%
Buyback Yield	-2.94%
Shareholder Yield	1.63%
Earnings Yield	5.71%
FCF Yield	4.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4